Introduction
Nitric oxide (NO) is a ubiquitous signaling molecule that has been recognized as the major endothelium-derived vasodilator [1] . In blood vessels, NO is synthesized in endothelial cells by endothelial NO synthase (eNOS) [2] , which is targeted to the plasma membrane by co-and post-translational acylation with myristate and palmitate, respectively. While myristoylation is required for membrane association, palmitoylation determines and stabilizes subcellular targeting of eNOS to caveolae [3] [4] [5] [6] . In caveolae, eNOS is associated to caveolin-1 (Cav-1), an integral membrane protein of this microdomain [7, 8] . The interaction of eNOS with Ca 2+ -calmodulin during an increase in intracellular Ca 2+ concentration, [Ca 2+ ] i releases eNOS from the inhibitory influence of Cav-1 and leads to NO production [9, 10] . Additionally, an increase in Ca 2+ induces eNOS translocation from the cell membrane to the cytosol [11, 12] , or to intracellular perinuclear sites, most likely the Golgi complex [13] . Although in those experiments eNOS translocation was not analyzed in parallel with NO production, translocation was assumed to correspond to an inactivation mechanism of eNOS, because this process was slower than the expected kinetics of NO production [11] [12] [13] . However, in the hamster microcirculation in vivo, translocation of eNOS observed in response to acetylcholine (ACh) was concomitant with NO production and vasodilatation [14] . The mechanisms that regulate eNOS translocation and NO function require further studies to elucidate the requirement of Ca 2+ and the subcellular target dependence on stimulus and type of blood vessel [15] [16] [17] .
In addition to the subcellular location and proteinprotein interactions, several phosphorylation and dephosphorylation sites modulate eNOS activity [18] . In particular, Akt (protein kinase B)-mediated eNOS phosphorylation at Ser-1177 increases the activity of the enzyme and reduces its Ca 2+ dependency [19, 20] . Fluid shear stress, the dragging force generated by blood flow, is considered the major physiological stimulus for tonic eNOS activation [21] [22] [23] and, thereby, for NO-dependent control of peripheral vascular resistance [24] [25] [26] [27] . The mechanisms linking shear stress with NO release are incompletely understood. Although it is recognized that eNOS phosphorylation at Ser-1177 by the PI3K-Akt pathway plays a central role in the response to shear stress [19, 28, 29] , the contribution of eNOS translocation and the requirement of Ca 2+ in this physiological regulation are controversial. In this context, results in cultured endothelial cells differ from those reported in isolated arterioles. In cultured endothelial cells, an increase in shear stress induced a biphasic rise in NO release initiated by Ca 2+ -mediated eNOS activation [30] , while, in isolated arterioles, shear stress-induced NO-dependent dilation was not associated with a rise in intracellular Ca 2+ concentration [31, 32] . Even though shear stress apparently induces translocation of eNOS in cells in culture [33] , the role of Ca 2+ , as well as the interactions between translocation and phosphorylation of eNOS in response to shear stress in arterioles, remains to be determined.
In this study, we tested the hypothesis that increases in shear stress in intact vessels cause eNOS phosphorylation and subcellular translocation from caveolae at the plasma membrane to intracellular compartments and lead to flow-induced NO release. We evaluated the changes in eNOS subcellular distribution and phosphorylation at Ser-1177 induced by an increase in the perfusion flow rate in the arterial mesenteric bed to analyze in an integrative manner the relevance of eNOS translocation and/or phosphorylation as a function of time. In addition, we analyzed the requirement of extracellular Ca 2+ in the response to flow changes.
Methods

Animal and Drug Sources
Male Sprague-Dawley rats (290-310 g) were obtained from the Institutional Animal Facilities of the P. Universidad Católica de Chile (PUC). All studies were conducted in compliance with the Committee for Bioethics and Biosecurity of the Facultad de Ciencias Biológicas, PUC, following the Guiding Principles in the Care and Use of Laboratory Animals endorsed by the American Physiological Society.
Unless specified otherwise, all biochemical reagents and inhibitors were purchased from Sigma Chemical Co. (St Louis, Mo., USA) and chemicals of analytical grade were from Merck (Darmstadt, Germany). Monoclonal anti-phospho-Ser1177-eNOS, antieNOS and polyclonal anti-caveolin antibodies were purchased from BD-Transduction Labs (Lexington, K.Y., USA). Horseradish peroxidase-linked goat anti-rabbit and goat anti-mouse secondary antibodies were purchased from Pierce (Rockford, Ill., USA).
Perfusion of Rat Arterial Mesenteric Bed
Rats were anesthetized with sodium pentobarbital (40 mg/kg i.p.). The mesenteric artery was exposed through a mid-line incision and cannulated. The mesenteric vascular bed was severed from the intestinal wall, perfused with Tyrode solution at 37 ° C and equilibrated with 95% O 2 and 5% CO 2 to yield a pH ∼ 7.4 [34] . We refer to this preparation as the arterial mesenteric bed because only this side of the circulation was perfused and, therefore, the measurements of NO and variations in eNOS location and phosphorylation mainly reflect the response of resistance vessels to changes in flow. Under deep anesthesia, rats were killed by bleeding and pneumothorax. The baseline mesenteric perfusion flow rate was set at 2 ml/min with a peristaltic pump (Gilson Minipuls-3). Perfusion pressure was continuously recorded with a transducer (P23X Statham) connected to a Grass 7D polygraph. In all cases, a 30-min equilibration period was allowed before starting the experimental protocol.
Experimental Protocols
Flow Change Perfusate output was collected every minute in test tubes for determination of NO. A 20-min experiment was performed in the following sequence: 5 min at 2 ml/min (baseline), 10 min at 1, 5 or 10 ml/min (stimulus), and 5 min at 2 ml/min (recovery). One group was perfused at 2 ml/min for the duration of the experiment as a time control. The flow rate was changed by rapid acceleration of the pump ( ∼ 0.8 ml/min/s); perfusate was not collected during flow-change intervals.
Figueroa /González /Puebla /Acevedo / Rojas-Libano /Durán /Boric To confirm NOS as the source of NO, some mesenteric beds were stimulated with flow changes in the presence of 30 μ M N ω -nitro-L -arginine ( L -NNA). Application of L -NNA was initiated 45 min before starting the experimental protocol, and maintained throughout the experiment by continuous perfusion.
Effect of Ca 2+ Removal
To test the effect of extracellular Ca 2+ , mesenteries were equilibrated for 30 min with normal Tyrode and basal NO release was measured for 3 min. Thereafter, the solution was changed to a modified Tyrode solution, without Ca 2+ and containing 1 m M EGTA (Ca 2+ -free buffer). The mesentery was submitted to the 20-min flow-change protocol (5 ml/min stimulus). The role of intracellular Ca 2+ was assessed in separate mesenteries perfused throughout the equilibration (30 min) and experimental periods with Ca 2+ -free buffer supplemented with 10 m M of caffeine to deplete intracellular Ca 2+ stores. In addition, to study the early component of flow-induced NO release in separate experiments, mesenteries were equilibrated and perfused with normal or Ca 2+ -free buffer, and the perfusate output was collected every 15 s during the first minute after raising the flow from 2 to 10 ml/min. To test the role of the PI3K-Akt pathway in eNOS phosphorylation, additional mesenteries were perfused with 1 μ M wortmannin for 15 min, and then stimulated with the 5 ml/min flow-change protocol.
eNOS Translocation and Phosphorylation To ascertain changes in the subcellular location and phosphorylation of eNOS, we homogenized mesenteries at different times of the stimulation protocol. The sampling times were based on the measurements of NO release in response to flow changes to evaluate the basal (min-5), transient (min-6), sustained (min-12) and recovery (min-17) responses. These studies were performed with the flow stimulus of 10 ml/min. The association of eNOS with Cav-1 was determined in basal conditions (min-5) and after 1 min of stimulation (min-6). All biochemical analyses were performed in whole homogenized mesentery, which includes venular vessels.
eNOS Subcellular Location To directly assess the eNOS distribution in endothelial cells of intact resistance vessels, some mesenteries were processed for immunofluorescence analysis by confocal microscopy. Mesenteries were prepared, as described above, and then the vasculature was fixed by perfusing 2% paraformaldehyde for 5 min in control conditions (2 ml/min) or 1 min after increasing the flow rate from 2 to 10 ml/min. Mesenteries were kept in 2% paraformaldehyde for 48 h and a resistance artery of 120-180 μm was isolated to perform the immunofluorescence procedure.
Measurements
Determination of NO The perfusate content of NO plus nitrite was quantified by chemiluminescence using an NO analyzer (Sievers 280, Boulder, Colo., USA) [35] [36] [37] . The equipment sensitivity detection threshold was ∼ 10 pmol/ml (0.5 pmol in 50-μl sample volume). The net NO/nitrite mesenteric output was expressed in pmol/min.
Subcellular Fractionation
The external, nonglandular portions of the mesentery were rapidly excised ( ∼ 15 s) and homogenized with an Ultraturrax in 1 ml of cold antiprotease-lysis buffer. The crude extract was centrifuged for 5 min at 150 g to obtain a clear total homogenate, which was then centrifuged for 30 min at 10,000 g and for 90 min at 100,000 g to obtain Golgi, microsomal and cytosolic fractions, as described previously [14] .
Immunoprecipitation
The degree of association of eNOS with Cav-1 was assessed by immunoprecipitation using slight modifications of previously reported methods [37] . Total homogenate (1 mg protein) was precleared with protein-A bearing Staphylococcus aureus (Pansorbin, 450 μl 10%-wt/vol) and incubated for 1 h with 10 μg of anti-caveolin polyclonal antibody. Bound protein was precipitated with 450 μl of Pansorbin, resuspended in Laemmli's buffer and submitted to SDS-PAGE and Western blot for eNOS and Cav-1.
Western Blotting Protein samples of each fraction (30-100 μg, Bradford method) were separated by 7.5% SDS-PAGE and blotted onto a PVDF or nitrocellulose membrane (Bio-Rad, Hercules, Calif., USA). The membrane was incubated with a primary antibody overnight at 4 ° C and then with an appropriate secondary antibody (2 h at room temperature). The primary antibodies were used at the following dilutions: anti-eNOS 1: 2000; anti-Cav-1 1: 2500; anti-P-eNOS 1: 1000. The same membrane was analyzed first for phosphorylated eNOS and then for total eNOS protein, after stripping. The protein bands were visualized with standard methods, using Western Lighting TM Chemiluminescence reagent (Perkin Elmer, Boston, Mass., USA), SuperSignal ® West Femto (Pierce, Rockford, Ill., USA) or with 0.01% 3,3 ′ -diaminobenzidine, 0.5% H 2 O 2 in the dark according to the strength of the signal. Western blots were scanned and evaluated by densitometric analysis using NIH-image software. A pooled sample of 8 naïve mesenteries was used as internal standard to standardize the signal strength among different blots when comparing the ratio of P-eNOS/total eNOS.
Immunocytochemistry
The expression of eNOS was analyzed by immunohistochemistry in cross sections and by immunofluorescence in whole mount intact vessels. For immunohistochemistry, mesenteries were perfused with Bouin's fixative for 5 min at 2 ml/min and postfixed overnight. Then, tissues were dehydrated, embedded in paraffin, sectioned at 10 μm, placed in silanized slides and deparaffinized using standard procedures. Tissue sections were blocked with 3% BSA in TBS (pH 7.4) for 1 h at room temperature and prepared as indicated by the Mouse/Rabbit ImmunoDetector System (Bio SB, Santa Barbara, Calif., USA) protocol. After blocking the endogenous peroxidase activity, sections were incubated overnight at 4 ° C with an antieNOS monoclonal primary antibody and the signal was developed using the biotin link secondary antibody (10 min), HRP label and DAB chromogen of the Mouse/Rabbit ImmunoDetector System. The sections were observed with an Olympus BX 41 microscope and a Jenoptik ProRes C5 camera. For immunofluorescence in intact vessels, isolated resistance arteries fixed with 2% paraformaldehyde were cut longitudinally and permeabilized with 0.01% Triton X-100 and blocked with 3% BSA. Triton X-100 and BSA were diluted in TBS (pH 7.4) and applied for 24 h at 4 ° C. The permeabilized and blocked arteries were incubated for 24 h at 4 ° C with anti-eNOS monoclonal primary antibody, and then with Alexa-568-labeled goat anti-mouse secondary antibody (Molecular Probes, Eugene, Oreg., USA) for 4 h at 4 ° C. The fluorescent signal was examined with an Olympus LSM Fluoview 1000 confocal microscope.
Statistical Analysis
Results are expressed as mean ± SEM. Paired or unpaired Student's t tests and one-way ANOVA plus Newman-Keuls post hoc test were used to assess the significance of variations over time within or between the groups, as appropriate. A value of p < 0.05 was considered statistically significant. Nonparametric MannWhitney or Kruskal-Wallis tests were used to compare the ratios of phospho-Ser1177-eNOS/eNOS densitometric intensities.
Results
Flow-Induced NO Production
At basal flow rate (2 ml/min), the perfusion pressure was 8.7 ± 0.7 mm Hg (n = 16). During stimulation, this perfusion pressure changed linearly with flow, averaging 5.8 ± 0.6, 8.6 ± 1.3, 15.1 ± 3.1 and 27.6 ± 2.0 mm Hg at 1, 2, 5 and 10 ml/min, respectively (n = 4 in each experimental group). In all instances, perfusion pressure returned to baseline immediately after the end of stimulation.
Baseline NO production was 282 ± 14 pmol/min (range 210-440 pmol/min, n = 24). In time-control experiments, NO release observed during perfusion at 2 ml/min showed a slow decay along the 20-min protocol ( fig. 1 a) . Raising flow to 5 or 10 ml/min induced a proportional increment in NO production that exhibited two clearly distinct phases ( fig. 1 a) . The flow rise produced an initial NO peak in the first minute, followed by a gradual decrease in the next 2-3 min to a stable level that remained above baseline until the end of the stimulus. We named these phases as transient and sustained, respectively. The latter phase was not a washout of the initial peak, because NO release remained above and parallel to the time-control group for several minutes and returned abruptly to control level at the end of the stimulation period ( fig. 1 a) . Contrariwise, changing the flow to 1 ml/min caused a rapid reduction in NO production, which was sustained at about one-half of baseline and returned to control at the end of the experimental period ( fig. 1 a) . In mesenteries treated with 30 μ M L -NNA, basal NO release was reduced ( fig. 1 b) and the increase in NO production induced by stimulation with 5 and 10 ml/min was dramatically blocked, confirming the measurement of NOS-derived NO. In addition, consistent with the ab- plots ( a , b ) , the control response of mesenteries perfused with normal medium (data from fig. 1 ) is shown in dotted lines for comparison. c Net increment in NO release above baseline in response to flow increase from 2 to 5 ml/ min at the peak (min-6) and sustained (average min 12-15) phases in mesenteries perfused in control medium (data from fig. 1 ), Ca 2+ -free buffer ( a ) and Ca 2+ -free plus caffeine buffer ( b ). * p < 0.05 versus control (one-way ANOVA, Newman-Keuls test); † p < 0.05 versus peak (paired t test). d Early transient phase of flowinduced NO production. Mesenteries perfused in control medium or in Ca 2+ -free plus EGTA medium were submitted to a flow increase from 2 to 10 ml/min. NO production was measured every 15 s. Flow change took ∼ 10 s. 
Requirement of Ca
2+
Perfusion with a Ca 2+ -free medium supplemented with EGTA did not affect baseline NO production ( fig. 2 a) . Increasing flow to 5 ml/min produced a rapid increment in NO that showed only the sustained phase while the transient component of the response was absent ( fig. 2 a) . Depletion of intracellular Ca 2+ stores by prolonged (30 min) perfusion with Ca 2+ -free buffer plus caffeine also produced loss of the initial transient NO peak ( fig. 2 b) .
The magnitude of the NO release response induced by stimulation at 5 ml/min in mesenteries perfused with control medium and two different Ca 2+ -free media was analyzed by comparing the peak and sustained phases ( fig. 2 c) . This analysis confirmed that absence of Ca 2+ abolished the transient component of NO release but did not impact the sustained phase.
In addition, in separate experiments, we analyzed the early part of the response by collecting samples every 15 s during the first minute of stimulation with 10 ml/min ( fig. 2 d) . This enhanced time resolution revealed that, in control conditions, flow-induced NO release was rapid, peaking in the first 15 s and starting to decrease gradually thereafter. In the absence of extracellular Ca 2+ , the rise in NO was equally rapid, but NO levels immediately attained a steady level ( fig. 2 d) . eNOS Dissociation from Cav-1 and Translocation Subcellular analysis of the mesenteric vessels revealed that under basal flow perfusion at 2 ml/min, eNOS was mainly located in the microsomal fraction ( fig. 3 a) of endothelial cells ( fig. 4 a-c) , but was also found in the Golgienriched fraction and cytosol. Flow increase to 10 ml/min for 1 min caused eNOS translocation to the cytosolic and Golgi fractions ( fig. 3 a) , which was confirmed by immunofluorescence analysis of intact mesenteric resistance vessels ( fig. 4 d) .
Concomitantly with eNOS translocation, flow increase caused a rapid dissociation of eNOS from Cav-1 ( fig. 3 b) . At basal flow, a clear eNOS band was detected in the Cav-1 immunoprecipitate, confirming the association of both proteins in intact vessels. After a 1-min stimulation with 10 ml/min, the amount of eNOS co-precipitated with Cav-1 was drastically reduced, in agreement with the decrease in microsomal eNOS content ( fig. 3 a) . In contrast, co-immunoprecipitation analysis carried out in mesenteries perfused in the absence of Ca 2+ indicated that flow-induced NO production in these conditions occurred without detectable dissociation of eNOS from Cav-1 ( fig. 3 b) . The reduced eNOS content in the Cav-1 immunoprecipitate observed at 10 ml/min in control conditions can only be ascribed to dissociation between the two proteins, because total eNOS content as well as the amount of immunoprecipitated Cav-1 was similar in mesenteries perfused at 2 or 10 ml/min, in control and Ca 2+ -free conditions ( fig. 3 b) .
Based on these results, we performed a time-course analysis of the effect of flow on the microsomal eNOS content, both in the presence and absence of extracellular Ca
. In normal Ca 2+ containing medium, flow increase produced a rapid and reversible reduction of microsomal eNOS content, which mirrored NO production measured in the same mesenteries ( fig. 5 a-c) . Microsomal eNOS was reduced by 48 ± 8% relative to the control, during the peak of the initial phase (min-6), which was associated with a 4-fold increase in NO production ( fig. 5 a, c) . During the sustained phase (min-12) microsomal eNOS was not different from basal, while NO release remained at twice the baseline ( fig. 5 a, c) . Two minutes after ending the stimulus (min-17), microsomal eNOS content and NO release returned to the level observed in basal condi- tions. Statistical analysis confirmed the inverse relationship between NO production and microsomal eNOS content ( fig. 5 d) . Consistent with the results observed in Cav-1 co-immunoprecipitation, microsomal eNOS content did not change throughout the Ca 2+ -free stimulation protocol ( fig. 5 b, c) , though NO production increased to approximately twice the baseline value during the period of perfusion at 10 ml/min, and remained at the same level in measurements performed at min-6 and min-12, confirming the lack of a transient phase in this condition ( fig. 5 a) . Accordingly, statistical analysis showed no correlation between NO production and microsomal eNOS content in the absence of extracellular Ca 2+ ( fig. 5 d) .
eNOS Phosphorylation at Ser1177
We then studied the role of the PI3K-Akt pathway in flow-induced eNOS activation. In control mesenteries perfused at basal flow, either with a normal or a Ca 2+ -free medium, there was a detectable level of phospho-Ser1177-eNOS ( fig. 6 a) . After a 1-min stimulation with 10 ml/min, -dependent reduction on microsomal eNOS content. Mesenteries were perfused with control medium (left) or with Ca 2+ -free medium containing 1 m M of EGTA (right), and homogenized and processed for subcellular fractionation at different times before, during and after stimulation with 10 ml/min, following the protocol depicted in figure 1 . a NO production determined in the mesenteries just before homogenization; the number of experiments appears inside the columns. One-way ANOVA indicated significant differences in control (F (3,12) = 51.7, p < 0.00001), and Ca 2+ -free (F (3, 8) = 9.4, p < 0.006) conditions; † p < 0.001 versus all other groups; * p < 0.05 versus min-5 and min-17, Newman-Keuls post hoc test. b Representative Western blots showing eNOS content of the microsomal fraction in each condition (70 μg protein). c Densitometric analysis of all experiments; the number of tissues processed in each condition appears inside the columns. In control conditions there were significant differences in microsomal eNOS content between time points (F (3,22) = 4.70, p < 0.02, one-way ANOVA; * p < 0.05 vs. min-5 and min-17, NewmanKeuls post hoc test). No differences were detected in Ca 2+ -free conditions (F (3, 8) = 0.54, p < 0.67, n.s.). d A significant inverse correlation between NO production and microsomal eNOS content was found in mesenteries perfused with normal medium; whereas no significant correlation between both variables was detected in Ca 2+ -free conditions (these analyses include all experiments in which both measurements were performed in parallel, data from panels a and c ). Figueroa /González /Puebla /Acevedo / Rojas-Libano /Durán /Boric a similar increment in eNOS phosphorylation was evident in both conditions. As expected, this increase in phospho-Ser1177-eNOS was associated with an increase in the level of phosphorylated Akt at Ser473 (data not shown).
To analyze the phosphorylation of eNOS (P-eNOS/total eNOS) in relation to the changes in eNOS subcellular distribution observed as a function of time, we used the same time points chosen to assess eNOS translocation. This analysis ( fig. 6 b) corroborated that eNOS was phosphorylated during the transient phase (min-6), remained phosphorylated during the sustained phase (min-12) and returned to basal phosphorylation levels after the end of stimulation (min-17).
In order to assess the spatial relation between eNOS phosphorylation and translocation, we also analyzed the ratio of P-eNOS/total eNOS in subcellular fractions before and after the flow change. This analysis showed an increment in the phosphorylation only in the enzyme located at the cytosol ( fig. 6 c) .
The relevance of the PI3K-Akt pathway in the eNOS phosphorylation and NO production in response to changes in flow was assessed using the PI3K blocker wortmannin. Although application of 1 μ M wortmannin did not affect the baseline of NO release, this treatment abolished the sustained phase of NO production induced by stimulation with 5 ml/min ( fig. 7 ) and reduced in a similar magnitude the transient peak ( fig. 7 ).
Discussion
The major finding of the present study is that, in intact resistance vessels, flow-associated shear stress leads to NO production by the coordinated activation of two signaling pathways: the Ca 2+ -dependent translocation of eNOS from the membrane to intracellular compartments and the Ca 2+ -independent phosphorylation of eNOS at serine 1177 through the PI3K-Akt pathway. Although both signaling pathways are activated rapidly in parallel, eNOS translocation is transient, and then only contributes to the initial phase of flow-induced NO release. As a result, the tonic NO production observed in response to flow is maintained by the phosphorylation of the enzyme. Flow induces eNOS phosphorylation at Ser1177. a Mesenteries were perfused either in control medium or Ca 2+ -free medium and homogenized at basal flow (2 ml/min, min-5) or after 1 min of stimulation with high flow (10 ml/min, min-6) and processed to detect phospho eNOS (Ser1177, P-eNOS) and total eNOS content. Representative Western blots and corresponding densitometric analysis; the number of tissues processed in each condition appears inside the columns. P-eNOS/eNOS signal ratio is expressed in arbitrary units relative to an internal standard included in each blot. Flow caused rapid eNOS phosphorylation regardless of Ca 2+ availability. * p < 0.05 min-6 versus min-5, Mann-Whitney test. b Representative Western blots of P-eNOS and total eNOS content, and densitometric analysis of P-eNOS to total eNOS content ratio in six similar experimental series. Persistent eNOS phosphorylation was determined in mesenteries perfused in control medium and homogenized at different times before, during and after stimulation at 10 ml/min (as indicated). * p < 0.05 versus basal, Kruscal-Wallis test. c Increased P-eNOS (ser1177) was detected in the cytosolic fraction. Mesenteries perfused in control medium were homogenized at basal flow (2 ml/min) or after 1 min of stimulation with 10 ml/min, submitted to subcellular fractionation and processed to detect p-eNOS and total eNOS content in subcellular fractions. * p < 0.05 versus basal, Mann-Whitney test.
Translocation and phosphorylation of eNOS are not two independent mechanisms, since our results suggest that flow induces the translocation of phospho-Ser1177-eNOS, which may contribute to enhance the initial, transient NO production.
Experimental Model and Flow Stimulus
We chose to study the mechanisms of flow-induced eNOS activation in the isolated perfused arterial mesenteric bed because this preparation offers several advantages to the study of the transduction signals connecting shear stress with eNOS activation: first, intact resistance vessels can be stimulated in controlled conditions of flow; second, changes in NO production can be recorded as a function of time, and third, the subcellular distribution and phosphorylation degree of eNOS can be evaluated in a single mesentery [35] . We specifically avoided the use of vasoconstrictor agents because it has been shown that [Ca 2+ ] i changes in smooth muscle cells can spread to adjacent endothelial cells leading to increases in NO release [38] [39] [40] . In our model, perfusion pressure changed in direct proportion to flow, confirming that the arterial mesenteric bed preparation does not develop myogenic constriction, which facilitates our goal to assess the mechanisms of endothelial cell signaling in response to changes in shear stress, in intact vessels, without interference of [Ca 2+ ] i variations in smooth muscle cells.
We used a Newtonian fluid; therefore, we are confident that flow changes were directly translated into equivalent changes in shear stress. Based on the diameter of the superior mesenteric artery (cannula's outer diameter 0.965 mm) and assuming a viscosity of 0.007 poise for bicarbonate buffer at 37 ° C, we calculated that shear stress at the major perfused arterial branch was 1.3, 2.6, 6.6 and 13 dynes cm -2 at 1, 2, 5 and 10 ml/min, respectively. These values are within the physiological range for medium-size arteries [41] , and it is reasonable to think that shear stress levels in downstream vessels were also within their respective physiological values because perfusate flow was allowed to distribute freely through the normal branching pattern of the rat mesenteric arterial network. Moreover, as arterial smooth muscle tone was not affected by the flow-change stimulus, the observed changes in NO production can be attributed only to a direct activation of endothelial cells. Although the lack of vasomotor tone precluded the assessment of the impact of NO release on vessel diameter, it has been reported that blood flow increases similar to those used here (4-6 times above baseline) caused maximal dilatation of arcading arterioles in vivo in this vascular bed [42] , as well as in skeletal muscle [43] . In addition, we have shown that similar amounts of NO release to those recorded in this study in response to flow increase caused significant relaxation in phenylephrine-constricted perfused rat mesenteric arteries in re- sponse to endothelium-dependent agonists [36] or perivascular nerve stimulation [35] . Therefore, we are confident that the measured changes in NO production translate into significant vasodilatation of resistance vessels in in vivo conditions.
Flow-Induced NO Release
The stimulation protocol produced temporary and sustained changes in NO production in the arterial mesenteric bed, while removal of extracellular Ca 2+ only abolished the initial transient peak without affecting the sustained phase. These findings are consistent with those previously reported in other preparations [44] . Likewise, transient and sustained phases in cumulative NO release have been observed in cultured endothelial cells exposed to laminar flow [30, 45] . In those works, both phases of the response were proportional to the intensity of the flow rate applied; however, only the first phase was abolished by calmidazolium, a Ca 2+ -calmodulin inhibitor. The initial NO release, characterized by a conspicuous rapid peak and a gradual decrease during the following 3-5 min to the sustained level, may be interpreted as the result of eNOS activation triggered by the brief period of flow acceleration (approximately 10 s to change from 2 to 10 ml/min). Consistent with this interpretation, we found that NO production reached its maximum within 15 s after starting stimulation ( fig. 2 ) . On the other hand, sustained NO production attests that the prevailing flow constitutes an efficacious stimulus for persistent eNOS activation in arteriolar endothelium. It is likely that flowinduced stable NO production largely contributes to the NO-dependent vasodilator tone exposed by NOS inhibition in vivo [24] [25] [26] [27] . In contrast, NO production elicited by receptor-dependent stimulation is essentially transient, despite continuous application of agents like noradrenaline, clonidine [36] , bradykinin or ATP [46, 47] .
Subcellular eNOS Distribution
We took advantage of the fact that eNOS is only expressed in endothelial cells of mesenteric vessels ( fig. 4 a,  b) ; thus, changes in eNOS signal in fractions of the whole homogenized mesentery necessarily represent changes in endothelium. Only the arterial side of the circulation was perfused and, consequently, only these vessels were stimulated by flow changes. Therefore, perfusate output corresponds to the arterial mesenteric bed; however, biochemical analysis of changes may have been underestimated by proteins belonging to the nonstimulated venular and lymphatic endothelium. By combining analysis of eNOS band intensities (n = 5) and the total protein content of each fraction (4,020 ± 190 μg cytosolic, 530 ± 17 μg microsomal, 450 ± 70 μg Golgi; n = 17), we estimated that in mesenteries perfused at 2 ml/min, approximately 50% of total mesentery eNOS was membrane bound, and distributed 3: 2 between the microsomal and Golgi fractions. This proportion of eNOS associated to membrane is similar to that found in rat lungs by immunolocalization [8] and slightly smaller than that reported in the hamster cheek pouch in vivo [25] . In cultured endothelial cells, it has been extensively reported that the eNOS content associated to membrane reaches 90-100% of total eNOS [3, 6, [11] [12] [13] 48] . These observations suggest that constant stimulation by blood flow maintains a certain amount of eNOS trafficking in the cytosolic and Golgi compartments.
Consistent with this hypothesis, our results indicate that a substantial fraction of eNOS was translocated from the microsomal compartment to the cytosolic and Golgi compartments during the first minute of post-flow stimulation ( fig. 3 ) , concurrent with the maximal enzyme activation in the transient phase. The subcellular localization of eNOS is ascribed according to operational definitions as microsomal fraction, Golgi compartment and cytosol, based on ultracentrifugation in tandem with Western blotting, as well as assessment by microscopy as we have shown previously [14, 17] . In this context, we have documented the relevance of eNOS translocation to Golgi in response to the endothelium-dependent vasodilator ACh in resistance arteries in vivo [14] and in cultured endothelial cells [17] . The eNOS translocation toward the Golgi compartment was further confirmed in this work by the confocal analysis of eNOS distribution in endothelial cells of intact mesenteric vessels ( fig. 4 c) . Then, in subsequent experiments, we only evaluated the effects of flow on the enzyme content in the microsomal compartment because the membrane-bound eNOS correspond to the activatable enzyme pool [8] [9] [10] 49] . Our results show that, in control conditions, an increase in flow reduces microsomal eNOS content in an inverse relationship with NO production. Indeed, we found a significant correlation between both variables in tissue samples collected during the basal, transient, sustained and recovery stages of the flow-change protocol ( fig. 5 ). During the period of maximal enzyme activation, a sizeable fraction of eNOS translocated away from membrane; however, during the sustained phase, there was no significant reduction in microsomal eNOS. Interestingly, in the absence of extracellular Ca 2+ , flow stimulation did not cause a reduction in the microsomal eNOS content ( fig. 5 ). These results support the idea that eNOS redistri-bution is associated with Ca 2+ -dependent enzyme activation as we proposed previously for the ACh-induced NO production observed in the hamster microcirculation in vivo [14] .
Translocation of eNOS from membrane to the cytosol and/or Golgi has been detected by immunofluorescence in resting cultured endothelial cells in response to ACh, bradykinin or estradiol [12, 13, 17] . While the reported ACh-induced eNOS translocation matches the time course of our experiments [17] , maximal eNOS translocation induced by bradykinin and estradiol was observed 5 min after drug application [12, 13] . Because bradykinin induces transient NO release within seconds in endothelial cells [50] , translocation was interpreted as an inactivation mechanism of eNOS [12] . The apparent discordance with our results could be explained by the different nature of the stimulus and/or the source and physiological state of endothelial cells, as well as by inherent differences between studies performed ex vivo versus in vitro.
eNOS is mainly found in plasma membrane caveolae in an inhibitory association with Cav-1 [7, 9, 51] . Other signaling molecules, such as receptors, G proteins, Ca 2+ channels/transporters, calmodulin, protein kinases and phosphatases are also present in caveolae [52, 53] . Caveolar location provides eNOS with special proximity to intracellular modulators that may facilitate its release from Cav-1 and subsequent activation. Consistent with this notion, disruption of caveolae in cultured endothelial cells and in rabbit aorta perfused ex vivo renders eNOS unable to be activated by flow [54] . In the present study, we used immunoprecipitation to explore whether eNOS activation by translocation implies Ca 2+ -dependent dissociation of the eNOS-Cav-1 complex. To avoid time-dependent spurious eNOS dissociation, we incubated fresh homogenates with anti-Cav-1 antibody for a relatively short period (1 h). Our results clearly confirm the association of eNOS with Cav-1 in mesenteries perfused at 2 ml/min either in the presence or absence of Ca 2+ ( fig. 3 ). In control conditions, flow stimulation rapidly (1 min) caused a reduction in this association, suggesting that initial eNOS activation involves dissociation of the enzyme from Cav-1, which probably triggers the translocation of the enzyme. As expected, eNOS dissociation from Cav-1 was prevented by the absence of extracellular Ca 2+ , which is also consistent with our finding that Ca 2+ is required for the eNOS translocation induced by flow. Although these results are in agreement with the flow-dependent eNOS dissociation from Cav-1 and association to Ca 2+ -calmodulin observed in the luminal surface of perfused rat lungs [8] , in those experiments, caveolar eNOS content was not affected by flow, which may be explained by the time elapsed between stimulation and tissue sampling that was relatively long (>10 min), perhaps allowing for eNOS relocation to caveolae. Taken together, the present evidence strongly supports the notion that eNOS dissociation from Cav-1 and further translocation is a process involved in the initial enzyme activation induced by an increase in shear stress and suggests that translocation accounts for the transient, Ca
2+
-dependent component of NO release. In this context, the activity of acyl-protein thio-esterase-1, which preferentially hydrolyses the palmitoylation of Ca 2+ -calmodulin-bound eNOS to plasma membrane [55] , may constitute the link between Ca 2+ availability and eNOS translocation.
eNOS Phosphorylation
Consistent with previous reports, we found that eNOS phosphorylation at Ser-1177 via the PI3K-Akt pathway contributes to flow-induced NO production. This conclusion is supported by the action of wortmannin, which inhibited the sustained phase of NO release without affecting the transient phase ( fig. 7 ). This is in agreement with the wortmannin-sensitive vasodilation observed in the hamster cheek pouch [56] . eNOS phosphorylation at Ser-1177 increased in the first minute after raising flow and remained phosphorylated throughout the stimulation period, which supports the notion that phosphorylation at Ser-1177 accounts for the sustained phase of flowinduced eNOS activation, but also contributes to the magnitude of the transient, Ca
2+
-dependent NO production activated by flow at the initiation of the stimulation. In addition, the rapid increase in phosphorylation of Ser-1177 was also detected after removing Ca 2+ from the extracellular solution, which suggests that the persistent association of eNOS with Cav-1 observed in these conditions does not preclude the activation of eNOS by phosphorylation. Therefore, these results indicate that an increment in flow triggers two parallel and additive mechanisms of eNOS activation: an increase in Ca 2+ influx and the Ca 2+ -independent phosphorylation of the enzyme. Although it has been proposed that eNOS localized at the plasma membrane as well as the Golgi complex may be regulated by phosphorylation [57] , the localization of eNOS at caveolae appears to be necessary for its shear stress-induced phosphorylation at Ser-1177 (Ser-1179 in bovine) in endothelial cells [54] . Interestingly, in the present study, the rapid increase in phosphorylation of Ser-1177 detected after 1 min of stimulation with flow was observed in the cytosolic compartment ( fig. 6 c) , which suggests that most likely eNOS was phosphorylated in ca-veolae at the plasma membrane and rapidly translocated to the cytosol. Flow also induced eNOS translocation to Golgi after 1 min of stimulation ( fig. 3 a) and a concomitant increase in phosphorylation was not observed in this subcellular compartment ( fig. 6 c) , suggesting that phosphorylation of Ser-1177 may delay the traffic of eNOS from membrane to Golgi.
In summary, our results fully support the working hypothesis that in intact resistance vessels, flow-induced NO release involves two parallel mechanisms of eNOS activation: (a) enzyme dissociation from Cav-1 and translocation away from the plasma membrane, which is short lasting and entirely dependent on extracellular Ca 2+ , and (b) there is a rapid, but more persistent, eNOS phosphorylation at serine 1177 via the PI3K-Akt pathway. Our results highlight Ca 2+ as a mediator of shear stress-induced eNOS activation, mostly relevant for the first minute of the stimulus. This rapid component may be important in the context of flow-induced dilatation for rapid adaptations to the change in network flow conditions. Conversely, sustained NO production attests that the prevailing flow constitutes an efficacious stimulus for persistent eNOS activation in arteriolar endothelium. Taking all together, we propose that recurrent flow fluctuations constitute a persistent stimulus reducing microsomal eNOS content, likely accounting for the smaller amount of enzyme found in this compartment in vivo, as compared with cultured endothelial cells grown in stationary conditions.
